Robinhood Markets, Inc.’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRV
Robinhood Markets, Inc.'s ACRV Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in Acrivon Therapeutics (ACRV) in Q3 2026: 37 shares worth $76. The stake represents ﹤0.01% of the portfolio and ranks #1161 among its holdings.
47 funds tracked by Wall St. Rank hold ACRV as of Q3 2026.
- Robinhood Markets, Inc. held 37 shares of Acrivon Therapeutics worth $76 as of Q3 2026.
- Acrivon Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
- Acrivon Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1161 holding.
- 47 funds tracked by Wall St. Rank held Acrivon Therapeutics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.